The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells.
Regeneron previously worked on a similar treatment for Ebola and MERS.
Read the full news release here.
More articles on pharmacy:
Walgreens pays $7.5M to resolve claims an employee impersonated a pharmacist
SwedishAmerican opens ScriptCenter, a self-serve pharmacy kiosk
Walgreens CEO talks strategy, skips buyout speculation at annual meeting
